Stock listing

Precision Biosciences, Inc.

Selected listing: PBS0 · SWB · EUR · DE

Precision Biosciences, Inc. (Stuttgart:PBS0), Health Technology. Latest release Sep 9, 2026: D2L Inc. Announces Second Quarter 2027 Financial Results.

PBS0:SWBEURDEUpdated October 2, 2026

Ticker: Stuttgart:PBS0
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Stuttgart
Currency: EUR

About Precision Biosciences, Inc.

The company focuses on developing innovative gene editing technologies and therapies. As a leader in its field, Precision Biosciences aims to advance the treatment of various diseases through its proprietary platform.

Latest news from Precision Biosciences, Inc.

D2L Inc. Announces Second Quarter 2027 Financial Results

September 9, 2026

Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study

August 24, 2026

Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update

August 6, 2026

Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026

July 31, 2026

Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones

July 27, 2026

All Precision Biosciences, Inc. news →

Research Precision Biosciences, Inc.

Precision Biosciences, Inc. company profile

View the public company page for Precision Biosciences, Inc. on 6ix.

Precision Biosciences, Inc. news

Read company news and market updates connected to Precision Biosciences, Inc..

Precision Biosciences, Inc. investor events

Find investor webinars, events, and replay context for Precision Biosciences, Inc..